Vascular endothelial growth factor: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Vascular Endothelial Growth Factor''' ('''VEGF''') is a signal protein produced by cells that stimulates the formation of blood vessels. It is a part of the system that restores the oxygen supply to tissues when blood circulation is inadequate. VEGF is a sub-family of growth factors, the platelet-derived growth factor family of cystine-knot growth factors. | '''Vascular Endothelial Growth Factor''' ('''VEGF''') is a signal protein produced by cells that stimulates the formation of blood vessels. It is a part of the system that restores the oxygen supply to tissues when blood circulation is inadequate. VEGF is a sub-family of growth factors, the platelet-derived growth factor family of cystine-knot growth factors. | ||
| Line 10: | Line 7: | ||
== Isoforms == | == Isoforms == | ||
VEGF exists in multiple isoforms, which are produced by alternative splicing of mRNA from a single, 8-exon VEGF gene. These isoforms have different properties and functions, influencing their ability to bind to receptors and extracellular matrix components. | VEGF exists in multiple isoforms, which are produced by alternative splicing of mRNA from a single, 8-exon VEGF gene. These isoforms have different properties and functions, influencing their ability to bind to receptors and extracellular matrix components. | ||
Latest revision as of 13:25, 24 April 2026
Vascular Endothelial Growth Factor (VEGF) is a signal protein produced by cells that stimulates the formation of blood vessels. It is a part of the system that restores the oxygen supply to tissues when blood circulation is inadequate. VEGF is a sub-family of growth factors, the platelet-derived growth factor family of cystine-knot growth factors.
Function[edit]
VEGF plays a crucial role in both vasculogenesis (the de novo formation of the embryonic circulatory system) and angiogenesis (the growth of blood vessels from pre-existing vasculature). It is a key regulator of endothelial cell function, promoting cell proliferation, migration, and survival.
Isoforms[edit]
VEGF exists in multiple isoforms, which are produced by alternative splicing of mRNA from a single, 8-exon VEGF gene. These isoforms have different properties and functions, influencing their ability to bind to receptors and extracellular matrix components.
Receptors[edit]
VEGF exerts its effects by binding to tyrosine kinase receptors on the surface of endothelial cells. The main receptors for VEGF are VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1), and VEGFR-3. Each receptor has distinct roles in mediating the biological effects of VEGF.
Clinical Significance[edit]
VEGF is involved in both normal and pathological processes. It is essential for wound healing and the formation of new blood vessels after injury. However, overexpression of VEGF can lead to diseases such as cancer, where it promotes tumor growth and metastasis by increasing blood supply to the tumor. Anti-VEGF therapies are used in the treatment of various cancers and eye diseases like age-related macular degeneration.
